Results 111 to 120 of about 15,163 (213)

Essential Thrombocythemia [PDF]

open access: yesAmerican Society for Clinical Laboratory Science, 2011
openaire   +2 more sources

How I treat essential thrombocythemia.

open access: yes, 2016
Essential thrombocythemia is an indolent myeloproliferative neoplasm that may be complicated by vascular events, including both thrombosis and bleeding.
RUMI, ELISA, CAZZOLA, MARIO
core   +1 more source

ESSENTIAL THROMBOCYTHEMIA: ETIOPATHOGENESIS AND THERAPEUTICS

open access: yes, 2017
Trabalho de Projeto do Mestrado Integrado em Medicina apresentado à Faculdade de MedicinaA trombocitémia essencial (TE) é uma neoplasia mieloproliferativa que resulta da proliferação clonal de progenitores hematopoiéticos da linhagem megacariocítica ...
Castilho, Bruno Eduardo de Miranda
core  

Essential thrombocythemia as underlying cause of malabsorption syndrome.

open access: yes, 2010
Essential thrombocythemia as underlying cause of malabsorption ...
Teofili, Luciana   +6 more
core  

Walsh & Hoyt: Essential Thrombocythemia

open access: yes, 2005
Essential thrombocythemia (primary thrombocythemia, hemorrhagic thrombocythemia, idiopathic thrombocythemia) is a chronic myeloproliferative disorder in which the predominant laboratory feature is a persistent, striking thrombocytosis with elevation of ...
John Kerrison, MD
core  

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

open access: yes, 2014
Patients with essential thrombocythemia may carry JAK2 (V617F), an MPL substitution, or a calreticulin gene (CALR) mutation. We studied biologic and clinical features of essential thrombocythemia according to JAK2 or CALR mutation status and in relation ...
Pietra, D   +19 more
core   +1 more source

Plenary Abstracts Session & Oral Presentations

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Acute myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor

open access: yes, 2004
Essential thrombocythemia (ET) rarely causes obstruction of coronary arteries or acute myocardial infarction. Treatment of acute myocardial infarction in patients with ET may be a problem due to the important role of platelets in the pathogenesis of ...
Özbay, G   +6 more
core   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy